CHINA PHARMA HOLDINGS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | $4.3M | $9.2M | $1.1M |
| FY2020 | $5.2M | $8.0M | $957.7K |
| FY2021 | — | $6.0M | $4.9M |
| FY2022 | — | $4.3M | $2.0M |
| FY2023 | — | $7.5M | $1.4M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | $4.3M | $9.2M | $1.1M |
| FY2020 | $5.2M | $8.0M | $957.7K |
| FY2021 | — | $6.0M | $4.9M |
| FY2022 | — | $4.3M | $2.0M |
| FY2023 | — | $7.5M | $1.4M |